The Group Curium is the world’s largest nuclear medicine company. At Curium, we have a singular focus – to develop, manufacture and supply world-class radiopharmaceutical products around the globe. With manufacturing facilities across Europe, Middle East and the United States, Curium delivers SPECT, PET and therapeutic radiopharmaceutical solutions for life-threatening diseases to over 15 million patients annually. Our proven heritage combined with a pioneering approach are the hallmarks to deliver innovation, excellence, and unparalleled service. As a fast-growing company in a niche market, Curium is today owned by a private equity fund with LBO financing scheme.
With over 775 M € revenues in 2025, Curium International is specialized into the production and marketing of 25+ radiopharmaceuticals products, covering 12 indications (such as oncology, cardiology, neurology pulmonary…). Our network provides optimal coverage across the world in the interest of healthcare professionals and their patients, with nearly 2,100 experienced employees and a network of 3 large manufacturing sites (Petten, Saclay and Gebze), 47 PET dedicated sites and 27 radiopharmacies.
Our team is looking for an International Brand Manager to support the development and launch of its radiopharmaceutical therapy (RPT) portfolio in prostate cancer.
This is a unique opportunity to shape an international marketing strategy from the ground up and contribute to Curium’s first product launch in this fast-evolving therapy area. Reporting to the International Marketing Director, you will play a key role in shaping and driving launch preparation readiness across our international markets, in close collaboration with our cross-functional teams Medical Affairs, Market Access, Pricing, Regulatory, Commercial and local teams.
Education and Experience(s)
Required skills / hard skills
Preferred skills / Soft skills
Ready to have an impact? Join us and help shape the future launch of radioligand therapy from scratch.
The above statements are intended to describe the general nature and level of work being performed by employees assigned to this classification. They are not intended to be construed as an exhaustive list of all responsibilities, duties and skills required of employees assigned to this position.
We believe diversity includes disability, and we actively encourage applications from people with disabilities. If you require any accommodations during the recruitment process, please let us know—we are happy to support you.

Curium is the global leader in nuclear medicine, providing life-changing diagnostics and treatment to patients all over the world.
We develop, manufacture and distribute world-class radiopharmaceutical products with a renewed focus on cancer, exploring untapped potential for new innovation.
We build on remarkable foundations and a legacy of providing reliable and consistent nuclear solutions to tens of thousands of patients every day. Our proven heritage combined with a pioneering approach are the hallmarks from which we provide life-changing diagnostics and therapeutics. Our people are the root of the incredible impact they have.
As part of our 2030 vision to become an oncology-focused nuclear medicine leader – both in diagnostics and therapy – we will expand our reach further into Japan and China, continuing to roll out our superior products to a global market. The impact of these investments on patients will be life changing.
Our cancer focus is currently in Neuroendocrine Tumors (NETs) and prostate cancer PSMA. We are also working on leveraging the power of AI to improve image quality and accuracy; to identify patterns to help diagnose pathologies and of course to better support physicians.
Our Promise
We strive to make the impossible possible and to be an organization that will change the face of medicine. Our diverse group of industry experts is unified under one strong and singular focus – to develop, manufacture and supply revolutionary diagnostic and therapeutic radiopharmaceuticals to our customers around the globe with unrivaled reliability and superior service.